Isao Ohsawa

Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function

Kisara Onda, Isao Ohsawa, Hiroyuki Ohi et al. · BMC Nephrology · 2011 · 94 citations · Full text

Efficacy and safety of garadacimab, a factor XIIa inhibitor for hereditary angioedema prevention (VANGUARD): a global, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Timothy Craig, Avner Reshef, H Henry Li et al. · The Lancet · 2023 · 94 citations

Thrombosis, Hypertension, Cardiovascular Disease +8

Relationships between Levels of Urinary Podocalyxin, Number of Urinary Podocytes, and Histologic Injury in Adult Patients with IgA Nephropathy

Rin Asao, Katsuhiko Asanuma, Fumiko Kodama et al. · Clinical Journal of the American Society of Nephrology · 2012 · 88 citations · Full text

Complement activation through the lectin pathway in patients with Henoch-Schönlein purpura nephritis

Morito Endo, Hiroyuki Ohi, Isao Ohsawa et al. · American Journal of Kidney Diseases · 2000 · 79 citations

Inflammation, Glomerulonephritis, Complement System +12

Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis

N. Sato, Isao Ohsawa, Seiji Nagamachi et al. · Lupus · 2011 · 72 citations